News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,062 Results
Type
Article (5527)
Company Profile (25)
Press Release (165509)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (41293)
Career Advice (66)
Deals (7641)
Drug Delivery (7)
Drug Development (25709)
Employer Resources (6)
FDA (4720)
Job Trends (3728)
News (80109)
Policy (8228)
Tag
Academia (591)
Accelerated approval (11)
Allergies (42)
Alliances (10661)
ALS (71)
Alzheimer's disease (430)
Antibody-drug conjugate (ADC) (126)
Approvals (5035)
Artificial intelligence (218)
Autoimmune disease (57)
Automation (19)
Bankruptcy (58)
Best Places to Work (3462)
Biosimilars (76)
Biotechnology (21)
Bladder cancer (109)
Brain cancer (23)
Breast cancer (341)
Cancer (2372)
Cardiovascular disease (185)
Career advice (62)
CAR-T (84)
CDC (4)
Cell therapy (251)
Cervical cancer (20)
Clinical research (23374)
Collaboration (756)
Compensation (443)
Complete response letters (10)
COVID-19 (1888)
CRISPR (42)
C-suite (324)
Cystic fibrosis (44)
Data (3227)
Depression (52)
Diabetes (153)
Diagnostics (2151)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (2)
Drug discovery (90)
Drug pricing (18)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (21590)
Editorial (3)
Employer branding (1)
Employer resources (5)
Events (27457)
Executive appointments (443)
FDA (6232)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (8)
Funding (606)
Gene editing (75)
Generative AI (10)
Gene therapy (207)
GLP-1 (205)
Government (1232)
Grass and pollen (3)
Guidances (186)
Healthcare (4425)
HIV (40)
Huntington's disease (16)
IgA nephropathy (26)
Immunology and inflammation (35)
Immuno-oncology (16)
Indications (47)
Infectious disease (2032)
Inflammatory bowel disease (42)
Inflation Reduction Act (3)
Influenza (77)
Intellectual property (87)
Interviews (6)
IPO (3485)
IRA (4)
Job creations (557)
Job search strategy (60)
JPM (3)
Kidney cancer (7)
Labor market (5)
Layoffs (50)
Legal (1663)
Liver cancer (34)
Longevity (3)
Lung cancer (349)
Lymphoma (212)
Machine learning (16)
Management (1)
Manufacturing (261)
MASH (62)
Medical device (3007)
Medtech (3020)
Mergers & acquisitions (4634)
Metabolic disorders (328)
Multiple sclerosis (52)
NASH (5)
Neurodegenerative disease (101)
Neuropsychiatric disorders (21)
Neuroscience (855)
NextGen: Class of 2026 (714)
Non-profit (787)
Now hiring (3)
Obesity (101)
Opinion (24)
Ovarian cancer (93)
Pain (73)
Pancreatic cancer (97)
Parkinson's disease (88)
Partnered (6)
Patents (163)
Patient recruitment (191)
Peanut (14)
People (11383)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (6514)
Phase 2 (9869)
Phase 3 (8896)
Pipeline (2325)
Policy (16)
Postmarket research (956)
Preclinical (2448)
Press Release (54)
Prostate cancer (115)
Psychedelics (3)
Radiopharmaceuticals (80)
Rare diseases (272)
Real estate (1121)
Recruiting (3)
Regulatory (7062)
Reports (11)
Research institute (702)
Resumes & cover letters (7)
Rett syndrome (22)
RNA editing (4)
RSV (36)
Schizophrenia (45)
Series A (89)
Series B (84)
Service/supplier (3)
Sickle cell disease (38)
Special edition (1)
Spinal muscular atrophy (62)
Sponsored (7)
Startups (464)
State (1)
Stomach cancer (1)
Supply chain (37)
Tariffs (2)
The Weekly (2)
Vaccines (424)
Venture capital (12)
Weight loss (35)
Women's health (29)
Date
Today (47)
Last 7 days (248)
Last 30 days (866)
Last 365 days (13197)
2026 (1248)
2025 (13527)
2024 (10824)
2023 (10275)
2022 (14252)
2021 (15448)
2020 (15195)
2019 (9338)
2018 (6865)
2017 (6860)
2016 (6472)
2015 (7848)
2014 (5710)
2013 (4764)
2012 (5452)
2011 (5653)
2010 (5671)
Location
Africa (97)
Alabama (23)
Arizona (40)
Arkansas (3)
Asia (8406)
Australia (971)
California (4363)
Canada (1209)
China (357)
Colorado (216)
Connecticut (257)
Delaware (214)
Europe (20337)
Florida (445)
Georgia (136)
Hawaii (3)
Idaho (7)
Illinois (367)
India (29)
Indiana (113)
Iowa (9)
Japan (252)
Kansas (13)
Kentucky (7)
Louisiana (5)
Maine (6)
Maryland (367)
Massachusetts (3335)
Michigan (75)
Minnesota (170)
Mississippi (1)
Missouri (45)
Montana (2)
Nebraska (3)
Nevada (56)
New Hampshire (84)
New Jersey (2900)
New Mexico (22)
New York (1441)
North Carolina (1426)
North Dakota (10)
Northern California (2150)
Ohio (102)
Oklahoma (4)
Oregon (13)
Pennsylvania (661)
Puerto Rico (4)
Rhode Island (14)
South America (223)
South Carolina (4)
South Dakota (1)
Southern California (1574)
Tennessee (61)
Texas (680)
United States (17672)
Utah (64)
Virginia (105)
Washington D.C. (17)
Washington State (327)
West Virginia (2)
Wisconsin (89)
171,062 Results for "qiagen n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
Press Releases
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
October 14, 2025
·
1 min read
Press Releases
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast
July 8, 2025
·
1 min read
Press Releases
QIAGEN Appoints Mark Stevenson to Supervisory Board
January 27, 2026
·
6 min read
Press Releases
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
February 5, 2026
·
8 min read
Press Releases
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
February 4, 2026
·
7 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
April 8, 2025
·
1 min read
QIAGEN N.V. to release results for Q1 2024 and hold webcast
QIAGEN N.V. announced plans to release results for the first quarter 2024.
April 9, 2024
·
1 min read
Press Releases
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
December 19, 2025
·
7 min read
1 of 17,107
Next
